| clinical samples |
cohort |
8 |
2 |
clinical, clinical samples |
| clinical trial |
cohort |
3 |
1 |
|
| clinical trials |
cohort |
6 |
3 |
underpowered early-phase clinical trials |
| clinicians |
cohort |
2 |
1 |
|
| CLM |
gene |
3 |
2 |
Colombian, Colombian in Medellin, Colombia |
| CLOCK |
gene |
5 |
3 |
Clock protein, circadian locomotor output cycles kaput |
| clonazepam |
drug |
2 |
1 |
|
| Clontech |
drug |
3 |
— |
|
| clozapine |
drug |
9 |
6 |
clozapine, clozapine (5.2 mg/kg/d) |
| clozapine-N-oxide |
drug |
2 |
1 |
CNO |
| CLTCL1 |
gene |
3 |
3 |
Cltc, clathrin heavy chain-like 1 |
| Clu |
gene |
4 |
2 |
apolipoprotein J, clusterin |
| Cluster 1 |
cohort |
3 |
2 |
|
| cluster B personality disorder |
phenotype |
3 |
3 |
|
| CMTM8 |
gene |
3 |
3 |
CKLF Like MARVEL Transmembrane Domain Containing 8, CKLF like MARVEL transmembrane domain containing 8, CKLF-like MARVEL transmembrane domain containing 8 gene |
| c-myc |
gene |
6 |
4 |
MYC |
| Cnih3 |
gene |
4 |
3 |
CNIH-3, Cnih3, Cornichon homolog 3, cornichon family AMPA receptor auxiliary protein 3, cornichon-3 |
| CNP |
variant |
5 |
3 |
CNPs, common copy number polymorphism, common copy number polymorphisms, copy number polymorphism, diallelic copy number polymorphism, human copy number variation |
| CNQX |
drug |
8 |
7 |
6-Cyano-7-nitroquinoxaline-2,3-dione, 6-cyano-7-nitroquinoxaline-2,3-dione, AMPA receptor blocker CNQX, AMPA/kainate receptor antagonist CNQX, CNQX (antagonist of AMPA receptors), competitive AMPA receptor antagonist |
| Cnr1 |
gene |
21 |
— |
CB1, CB1 receptor, CB1 receptors, CB1R, CB1Rs, Cannabinoid receptor 1, Cannabinoid receptor-1, Cnr1, cannabinoid 1 receptor, cannabinoid receptor 1, cannabinoid receptor 1 gene, cannabinoid receptor gene, cannabinoid receptor type 1, cannabinoid-1 receptor, type-1 cannabinoid receptor |
